Patents by Inventor Jennifer A. Stover

Jennifer A. Stover has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for monitoring drug activities in vivo
    Patent number: 7643943
    Abstract: Methods, systems and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. Numerous drug activity genes can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells are modulatable by CCI-779 or other drugs. Therefore, these genes can be used as surrogate markers for detecting or monitoring drug activities in vivo.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: January 5, 2010
    Assignee: Wyeth LLC
    Inventors: Michael E. Burczynski, Joseph Boni, Andrew J. Dorner, Natalie C. Twine, Jennifer Stover, William L. Trepicchio, Virginia Fitzpatrick, Fred Immermann
  • Methods for diagnosing RCC and other solid tumors
    Patent number: 7611839
    Abstract: Methods, systems and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies numerous disease genes that are differentially expressed in the peripheral blood of patients having RCC or other solid tumors relative to disease-free humans. These disease genes can be used as surrogate markers for detecting the presence or absence of RCC or other solid tumors.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: November 3, 2009
    Assignee: Wyeth
    Inventors: Natalie C. Twine, Michael E. Burczynski, William L. Trepicchio, Andrew J. Dorner, Jennifer A. Stover, Donna K. Slonim
  • Methods and Systems for Diagnosis, Prognosis and Selection of Treatment of Leukemia
    Publication number: 20080280774
    Abstract: The present invention provides methods, systems and equipment for the prognosis, diagnosis and selection of treatment of AML or other types of leukemia. Genes prognostic of clinical outcome of leukemia patients can be identified according to the present invention. Leukemia disease genes can also be identified according to the present invention. These genes are differentially expressed in PBMCs of AML patients relative to disease-free humans. These genes can be used for the diagnosis or monitoring the development, progression or treatment of AML.
    Type: Application
    Filed: February 16, 2006
    Publication date: November 13, 2008
    Applicant: Wyeth
    Inventors: Michael Edward Burczynski, Jennifer A. Stover, Frederick William Immermann, Andrew J. Dorner, Natalie C. Twine
  • Methods and apparatuses for diagnosing AML and MDS
    Publication number: 20070198198
    Abstract: Methods, systems and equipment for diagnosing or monitoring the progression or treatment of AML or MDS. This invention identifies a plurality of AML or MDS disease genes which are differentially expressed in bone marrow cells of AML or MDS patients as compared to disease-free humans. These AML or MDS disease genes can be used as molecular markers for detecting the presence or absence of AML or MDS. These genes can also be used for the early identification of MDS patients who eventually progress to AML.
    Type: Application
    Filed: April 23, 2007
    Publication date: August 23, 2007
    Applicant: Wyeth
    Inventors: Michael Burczynski, Andrew Dorner, Natalie Twine, William Trepicchio, Jennifer Stover
  • Methods and apparatuses for diagnosing AML and MDS
    Publication number: 20050202451
    Abstract: Methods, systems and equipment for diagnosing or monitoring the progression or treatment of AML or MDS. This invention identifies a plurality of AML or MDS disease genes which are differentially expressed in bone marrow cells of AML or MDS patients as compared to disease-free humans. These AML or MDS disease genes can be used as molecular markers for detecting the presence or absence of AML or MDS. These genes can also be used for the early identification of MDS patients who eventually progress to AML.
    Type: Application
    Filed: April 29, 2004
    Publication date: September 15, 2005
    Inventors: Michael Burczynski, Andrew Dorner, Natalie Twine, William Trepicchio, Jennifer Stover
  • Methods for monitoring drug activities in vivo
    Publication number: 20040235020
    Abstract: Methods, systems and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. Numerous drug activity genes can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells are modulateable by CCI-779 or other drugs. Therefore, these genes can be used as surrogate markers for detecting or monitoring drug activities in vivo.
    Type: Application
    Filed: March 5, 2004
    Publication date: November 25, 2004
    Inventors: Michael E. Burczynski, Joseph Boni, Andrew J. Dorner, Natalie C. Twine, Jennifer Stover, William L. Trepicchio, Virginia Fitzpatrick, Fred Immerman
  • Methods for diagnosing RCC and other solid tumors
    Publication number: 20040110221
    Abstract: Methods, systems and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies numerous disease genes that are differentially expressed in the peripheral blood of patients having RCC or other solid tumors relative to disease-free humans. These disease genes can be used as surrogate markers for detecting the presence or absence of RCC or other solid tumors.
    Type: Application
    Filed: November 21, 2003
    Publication date: June 10, 2004
    Applicant: Wyeth
    Inventors: Natalie C. Twine, Michael E. Burczynski, William L. Trepicchio, Andrew J. Dorner, Jennifer A. Stover, Donna K. Slonim